Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Helius Medical Technologies Inc.

Latest From Helius Medical Technologies Inc.

FDA Rejects Helius’ De Novo Application For PoNS To Treat Brain Injury

Helius Medical announced on April 10 that the US FDA has declined its de novo application for treating brain injury with its Portable Neuromodulation Stimulator.

Research & Development Approvals

Global Approvals Analysis: Emerging Markets Drive Volume Of OUS Approvals

The numbers of medical device approvals were up in most regions outside the US and the biggest surge, by percentage, was in approvals from emerging markets and the so-called BRIC countries. It remains to be seen if the trend will continue in 2018, but many companies are already counting on important non-US approvals coming in the next year.

Approvals Innovation
See All

Company Information

  • Industry
  • Medical Devices
    • Rehabilitation Equipment and Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Helius Medical Technologies Inc.
  • Senior Management
  • Phil Deschamps, Pres., CEO & Chmn.
    Joyce LaViscount , CFO & COO
    Jonathan Sackier, MD, CMO
  • Contact Info
  • Helius Medical Technologies Inc.
    Phone: (877) 564-0008
    642 Newtown Yardley Rd.
    Suite 100
    Newtown, PA 18940